Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Antoniou, K. Samara, I. Lasithiotaki, P. Pantelidis, N. Siafakas, A. Wells (Heraklion, Greece; London, United Kingdom). Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders. Eur Respir J 2012; 40: Suppl. 56, 1764

Member's Comments

No comment yet.

Related content which might interest you: Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung Source: Eur Respir J 2011; 37: 12-14 Year: 2011 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Involvement ferroptosis in COPD pathogenesis Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017 The pathomechanistic role of autophagy in lung fibrosis Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Role of coagulation cascade proteases in lung repair and fibrosis Source: Eur Respir J 2003; 22: 33S-35S Year: 2003 Role of coagulation cascade proteases and lung repair and fibrosis Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease Year: 2003 Procoagulant activity and signalling in fibroproliferative lung disease Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020